GF
TTOO

Gabelli Funds’s T2 Biosystems, Inc TTOO Stock Holding History

Gabelli Funds’s Portfolio TTOO Stock Details TTOO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-3
Closed -$8K – 1083
2020
Q1 		$8K Hold
3
– – ﹤0.01% 1075
2019
Q4 		$15K Hold
3
– – ﹤0.01% 1096
2019
Q3 		$33K Hold
3
– – ﹤0.01% 1108
2019
Q2 		$22K Buy
+3
New +$35.1K ﹤0.01% 1149

Other funds holding TTOO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Gabelli Funds's TTOO Position: Q2 2020 in Review

Gabelli Funds sold out of T2 Biosystems, Inc (TTOO) in Q2 2020, closing a stake of 3 shares — an estimated $8K sold.

Gabelli Funds first reported a position in TTOO in Q2 2019 and held it in 4 quarters. The position peaked at $33K in Q3 2019. 46 funds tracked by Wall St. Rank hold TTOO as of Q2 2020.

  • Gabelli Funds reported no remaining T2 Biosystems, Inc position as of Q2 2020 after selling out during the quarter.
  • Gabelli Funds sold 3 T2 Biosystems, Inc shares in Q2 2020, an estimated $8K.
  • Gabelli Funds first reported a position in T2 Biosystems, Inc in Q2 2019 and held it in 4 quarters.
  • Gabelli Funds's T2 Biosystems, Inc position peaked at $33K in Q3 2019.
  • 46 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2020.

Based on Gabelli Funds's 13F filing for Q2 2020, filed 13 Aug 2020.